Moreover, a comparison of the number of animals with unhealed defects (all controls) or healed defects (complete bony continuity across the defect site) showed that besides pentadecapeptide intramuscular application for 14 days (i.e., local application of bone marrow or autologous cortical graft), also following other pentadecapeptide BPC-157 regimens (local application, or intermittent intramuscular administration), the number of animals with healed defect was increased
News Release July 17, 2007 Concerned by weaknesses in FDA's new rules for dietary supplements, ConsumerLab.com acts to "raise the bar on quality" WHITE PLAINS, NEW YORK July 17, 2007 Disappointed by the lack of quality standards within the FDA's newly released Good Manufacturing Practices (GMPs) for dietary supplements, ConsumerLab.com has announced two initiatives today intended to "raise the bar on quality
Store in a cool, dry place, away from direct sunlight
This section is current as of June 2026